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ABSTRACT
The ability to synthesize custom de novo DNA
constructs rapidly, accurately and inexpensively is
highly desired by researchers, as synthetic genes
and longer DNA constructs are enabling to numer-
ous powerful applications in both traditional molec-
ular biology and the emerging field of synthetic
biology. However, the current cost of de novo
synthesis—driven largely by reagent and handling
costs—is a significant barrier to the widespread
availability of such technology. In this work, we
demonstrate, to our knowledge, the first gene
synthesis in a microfluidic environment. The use of
microfluidic technology greatly reduces reaction
volumes and the corresponding reagent and han-
dling costs. Additionally, microfluidic technology
enables large numbers of complex reactions to be
performed in parallel. Here, we report the fabrica-
tion of a multi-chamber microfluidic device and its
use in carrying out the syntheses of several DNA
constructs. Genes up to 1kb in length were
synthesized in parallel at minute starting oligonu-
cleotide concentrations (10–25nM) in four 500nl
reactors. Such volumes are one to two orders of
magnitude lower than those utilized in conventional
gene synthesis. The identity of all target genes was
verified by sequencing, and the resultant error rate
was determined to be 1 per 560 bases.
INTRODUCTION
It has long been recognized that the capacity to design and
synthesize genes and longer DNA constructs can be
enabling to a broad cross-section of applications within
molecular biology (1), including the study of large sets of
single genes (2), the design of genetic circuitry (3), the
engineering of entire metabolic pathways for target
molecule manufacture (4), and even the construction
and re-engineering of viral and bacterial genomes (5–7).
The core technology for custom DNA synthesis centers
on the assembly of pools of oligonucleotides (oligos),
typically less than 50nt in length, into increasingly larger
DNA molecules. These oligos, hereafter referred to as
‘construction oligos’, are synthesized by variations of
phosphoramidite chemistry (8), and are the building
blocks for the diﬀerent gene synthesis techniques devel-
oped thus far. The most widely reported methods for
building long DNA molecules involve variations of the
polymerase-mediated assembly technique shown in
Figure 1, collectively termed polymerase construction
and ampliﬁcation (PCA) (9–10). Here, much like in the
more conventional polymerase chain reaction (PCR),
three temperature steps are employed to denature, anneal
and elongate the various overlapping construction oligos
until, after multiple rounds of thermocycling, the desired
full-length DNA construct is obtained. Furthermore,
assembly and ampliﬁcation can be performed in a single
reaction with the introduction of amplifying primers (11).
Thus, once a minute quantity of full-length product is
assembled, this product is ampliﬁed as per PCR. Using
such polymerase-mediated techniques, researchers have
successfully synthesized DNA constructs as large as 12 (12)
and 15kb (11). A PCA process was also employed as the
ﬁrst step in generating a32kb DNA construct bySanti and
co-workers (13). In addition, signiﬁcant progress has been
made in correcting synthesis errors, which originate
primarily from the phosphoramidite synthesis of initial
oligonucleotide building blocks. The use of protein-
mediated error correction has been eﬀective in increasing
the accuracy of synthetic DNA (14–16), with error rates as
low as 1 per 10000bp reported (14).
Despite these promising results, signiﬁcant challenges
remain, most signiﬁcantly the cost and time of synthesiz-
ing long constructs. Currently, while conventionally
synthesized oligos are available at a cost on the order of
USD0.1 per nucleotide, the cost for custom gene synthesis
services is signiﬁcantly higher, at USD0.65–USD1.10 per
base pair, with the major expenditure components for
such long syntheses being attributable to reagent and
sample handling. Microﬂuidic technology provides an
elegant means to overcome these limitations. By scaling
reactions down to volumes of less than a microliter,
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Furthermore, microﬂuidic technology enables highly
parallelized synthesis along with the potential for auto-
mated sample handling and process integration.
In this article, we report what is, to our knowledge, the
ﬁrst gene synthesis conducted in a microﬂuidic environ-
ment. We have successfully conducted synthesis and
ampliﬁcation in a single reaction for a variety of genes
and gene segments, including GFP, OR128-1, DsRed, ble
(bleomycin resistance), a Holliday junction cleavase (hjc)
gene from the bacteriophage SIRV-1, and a variant alba
gene from Sulfolobus solfataricus. The identities of all
synthetic genes were veriﬁed by sequencing, and extensive
sequencing of DsRed enabled the determination of an
error rate for genes synthesized in a microﬂuidic environ-
ment, along with a comparison of error rates for genes
synthesized in standard PCR tubes. In other reports,
construction oligos were synthesized on the microscale,
cleaved from the surface and subsequently assembled in
macroscopic (5ml) reactions (11,18–19). In contrast, we
have synthesized these DNA constructs in parallel within
four 500nl reactors of a poly(dimethylsiloxane) (PDMS)
based microﬂuidic device. Furthermore, the minute
construction oligo concentrations utilized (10–25nM
each oligo) are signiﬁcantly lower than concentrations
attainable (without ampliﬁcation) from high-density
oligonucleotide microarrays. Thus, such a microﬂuidic
approach should be compatible with DNA microarray-
derived oligonucleotides (11), further reducing the cost of
this crucial reagent.
MATERIALS AND METHODS
Master mold fabrication
Devices utilized in this work employed ‘push-down’ valve
geometries for ﬂuidic valve actuation (20). Two master
molds were fabricated, one from which the ﬂuidic ‘ﬂow
layer’ could be cast, the other from which the ﬂuidic
‘control layer’ could be cast. The ﬂow layer master was
fabricated by ﬁrst rinsing a 4’’ silicon wafer (WaferNet) in
acetone and isopropyl alcohol, followed by wafer dehy-
dration at 2008C on a hot plate. Next, hexamethyldisili-
zane (HMDS, Sigma) was spun on the wafer at
4000r.p.m. to promote adhesion of the photoresist. A
layer of AZP 4620 positive photoresist (AZ Electronic
Materials) was then coated at 1500r.p.m. for 40s followed
by a 1h soft-bake at 908C. Upon completion of the soft-
bake, the wafer was then exposed for 20s at 50% intensity
using a UV ﬂoodlight (Uvitron, Int.), followed by
development. Next, the resist was placed on a hot plate
at 1508C for 1min to reﬂow the resist and achieve
rounded ﬂuid channels, thus enhancing sealing during
valve actuation.
The control layer master was fabricated by again
employing a solvent wash followed by wafer dehydration.
A layer of SU-8 50 negative photoresist (MicroChem)
was then coated at 1000r.p.m. followed by pre-exposure
bake steps of 658C for 10min and 958C for 30min. The
resist was then exposed for 40s at 50% intensity and post-
exposure baked at 658C for 1min and 958C for 10min
before being developed.
Finally, both ﬂow layer and control layer masters
were brieﬂy exposed to chlorotrimethylsilane (Sigma)
vapors for several minutes to promote release of the
elastomer from the master molds. All transparency
masks used for the various exposure steps were designed
in Adobe Illustrator and printed by PageWorks
(Cambridge, MA).
Microfluidic device fabrication
Approximately 30g of liquid PDMS pre-polymer (GE,
RTV 615) at a component A to B ratio of 5:1 was poured
onto the control layer master to a thickness of 1cm,
followed by partial curing in a convection oven at 808C for
45min. Liquid PDMS pre-polymer at a component A to B
ratio of 20:1 was coated onto the ﬂow layer master, at
2000r.p.m. for 60s and also partially cured at 808C for
45min. The PDMS control layer was then peeled from its
master, and individual devices were cut out with a razor
blade. Holes for control line inlet ports were cored with an
18G needle whose tip had been beveled and sanded down
for clean coring. Next, control layer devices (typically six
per wafer) were aligned and bonded to the PDMS-coated
ﬂow layer master, followed by additional curing for 45min
Figure 1. Schematic for gene synthesis by polymerase construction and
ampliﬁcation (PCA). Multiple rounds of oligo annealing and extension
by DNA polymerase generate successively longer DNA assemblies from
a starting pool of construction oligos, typically 550nt, until the full-
length gene is produced. The pool of heterogeneous DNA products is
enriched for the full-length species by ampliﬁcation in a separate
subsequent reaction, or in the same reaction by including amplifying
primers in the reaction mixture.
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oﬀ the ﬂow-layer molds, cored, and bonded overnight at
808C to 1mm thick glass cover slips coated with a thin
layer of partially cured PDMS (typically spun on at
2000r.p.m. for 40s, with a 20:1 polymer-to-curing-agent
ratio, and cured at 808C for 45min).
An example of a three-layer PDMS device capable of
parallel gene synthesis is shown in Figure 2. Colored food
dyes are used to emphasize various features of the device,
with red indicating actuation lines in the PDMS control
layer, blue (and green) indicating the four gene synthesis
reactors and yellow indicating a mesh of ﬂuid lines in the
control layer, hereafter referred to as a ‘water jacket’,
placed above the reactors to minimize sample evaporation
during thermocycling.
Parsing of genes
Several genes and gene segments were selected for
synthesis and parsed utilizing the program DNAWorks
(21) to generate the desired oligonucleotide sequences
for assembly and ampliﬁcation. The genes selected for
synthesis were: (1) a randomized amino acid sequence of
the alba gene from S. solfataricus (total length 327bp, 16
oligos); (2) a Holliday junction cleavase (hjc) gene from
the bacteriophage SIRV-1 (total length 390bp, 16 oligos);
(3) ble (bleomycin resistance, total length 461bp, 16
oligos); (4) DsRed (total length 733bp, 26 oligos); (5)
OR128-1 (total length 942bp, 32 oligos); and (6) a GFP
construct including a promoter and regulatory elements
(total length 993bp, 42 oligos), using the same sequence
reported in Carr et al. (14). All genes were parsed in
protein-mode, utilizing codon optimization with the
exception of GFP, which was parsed in DNA-only
mode. Relevant parameters for the parses selected from
DNAWorks for all synthesized gene and gene segments
are summarized in Supplementary Table I. Complete
DNAWorks output ﬁles can be found in Supplementary
Tables IIa–f.
PCA reaction mixtures
PCA reaction mixtures for each desired gene or gene
segment were prepared for utilization with the microﬂuidic
device. Each reaction mixture contained the following
concentration of reagents: 1mM dNTPs (250 mM each),
0.15U/ml of Pfu Turbo Hotstart DNA Polymerase
(Stratagene), 1 cloned Pfu Buﬀer (Stratagene), 0.1%
n-Dodecyl-b-D-maltoside (Sigma), 10 or 25nM of each
construction oligo depending on the construct and 500nM
of each amplifying outside primer. The addition of
amplifying outside primers enabled the synthesis and
ampliﬁcation of the desired DNA construct in a single
reaction. For synthesis of the full GFP construct and
DsRed, 10nM of each construction oligo was utilized,
while for all other genes and gene segments, 25nM of each
construction oligo was used.
Two segments of the GFP gene were also synthesized;
for these experiments, the ﬁrst pool consisted of oligonu-
cleotides 1–22, with 1 and 22 used as the primers to
amplify segment 1, which was 531bp in length. The
second pool consisted of oligonucleotides 21–42, with 21
and 42 used as the primers to amplify segment 2, which
was 529bp in length. Oligonucleotides were purchased
from Integrated DNA Technologies and Operon
Biotechnologies without additional puriﬁcation.
PDMSmicrochannel preparation
While PDMS has a number of superb characteristics
that make it, in many cases, an ideal material from
which automated biological platforms can be built, its
hydrophobicity has inhibited certain biological processes
due to a strong tendency for non-speciﬁc protein adsorp-
tion. PCR in ml and nl volumes generally suﬀers from
such surface eﬀects for a variety of materials because
of the high surface-area-to-volume ratio of reactors (22),
thus mandating some type of surface passivation. To
address this problem in PDMS, we have successfully
employed a nonionic surfactant, n-Dodecyl-b-D-maltoside
(DDM), as a passivating agent (23). DDM adsorbs
strongly to hydrophobic surfaces and, when included in
reaction mixtures, is capable of successfully eliminating
the majority of protein adsorption. Reaction mixtures
that did not include DDM or any other passivating
reagent failed to generate desired synthesis products.
Additionally, we found that devices exhibited the most
robust, reliable performance after having been extensively
thermocycled prior to conducting gene synthesis reactions.
While the mechanism for this is not yet clear, experiments
have shown a substantial increase in product yields when
devices were ﬁrst thermocycled with reactors containing a
mixture of 0.1% DDM, 1 Pfu Buﬀer and water for 100
cycles utilizing the following program: 948C for 30s,
558C for 30s, and 728C for 60s (data not shown).
Figure 2. Optical images of a microﬂuidic device capable of conducting
four parallel 500-nl reactions with various features emphasized with
food coloring. Left inset: gene synthesis chamber (blue and green)
and water jacket (yellow) layers. Right inset: ﬂuid inlet channel
(blue) overlaid with valve channel (red). Scale bars correspond to
200mm.
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an in situ adapter that facilitated thermal contact between
the heating block and the glass slide was utilized for all
thermocycling of microﬂuidic devices in this work.
Sample evaporation
Because of the high porosity of PDMS, during the course
of thermocycling signiﬁcant sample evaporation can
occur, thus altering reactant concentrations and subse-
quently reducing reaction eﬃciency, and in some cases
completely inhibiting synthesis. It has been found that the
addition of ﬂuid reservoirs in the vicinity of reaction
chambers can reduce sample evaporation (17); thus,
a water jacket composed of a mesh of ﬂuid lines 50mm
wide with 300mm spacing was designed in the control
layer above the four reactors. When ﬁlled with water and
actuated during thermocycling, the water jacket substan-
tially decreased reactor evaporation as observed
qualitatively.
Devicedesign and operation
The microﬂuidic device was designed with individual
reactor volumes of 500nl to facilitate analysis of reaction
products by polyacrylamide gel electrophoresis (PAGE).
The overall device architecture is quite simple, with only
three control lines necessary: a single valve to address all
reactor inputs, a single valve to address all reactor
outputs, and a control line for water jacket actuation.
An array of 50mm diameter posts present in each reactor
prevented chamber ceiling collapse. Reactor input and
output channels were 100mm wide, while control lines
were 300mm wide, thus ensuring a strong seal to prevent
sample evaporation from the reactor inlets and outlets
during thermocycling. Without such valving, evaporation
occurs almost instantaneously upon reaching the dena-
turation temperature.
All control lines were dead-end loaded with water by
backing with pressurized air to force any air initially
within the control lines out through the porous bulk
PDMS. PCA mixes were introduced into the device by
ﬁrst actuating the reactor output valve at 15psi and then
dead-end loading the four reaction mixes at 5–10psi into
the reactor. Once all air bubbles were pushed out of the
device, the inlet valve was closed to seal the reaction mix
for thermocycling. All control valves, including the water
jacket, were actuated and maintained at 15psi for the
duration of the synthesis reaction. Fresh devices that had
been extensively thermocycled as described were used for
each experiment.
Upon completion of sample loading, the device was
placed on the in situ adapter of the Eppendorf
Mastercycler Gradient and adhered with a small volume
of mineral oil. Thermocycling commenced by heating ﬁrst
at 948C for 2min to activate the polymerase, followed by
either 35 or 45 cycles of the subsequent program: 948C for
30s, 558C for 30s, and 728C for 60s. For synthesizing
GFP and DsRed, 35 cycles were utilized, while for
synthesizing all other gene and gene segments 45 cycles
were used. Upon completion of cycling, a ﬁnal 2min
extension at 728C was conducted. Samples were collected
by ﬂushing with 5 ml of deionized water in preparation for
analysis by PAGE.
It should be noted that while steel pins (New England
Small Tube Corp.) were utilized to interface polymer
control line tubing to the ﬂuidic device, for all reaction
mix introduction and collection steps, only polymer pins
were utilized to interface to device inlets and outlets, as it
has been reported that prolonged contact between
reaction mixes and steel can inhibit PCR (24).
All ﬂuid manipulations, including valving and pressure-
driven ﬂows, were controlled by individually actuated
solenoid valves (The Lee Co.) connected through a
custom-printed circuit board to a National Instruments
DAQ card. A LabVIEW software interface allowed
control over individual valves and ﬂuid lines, while air
ﬂow for pressure-driven ﬂuid manipulation was controlled
by standard pressurized air regulators (McMaster).
Control experiments
Several sets of control experiments were conducted. For
each PCA reaction mix, synthesis reactions were per-
formed both within the ﬂuidic and also in vitro in standard
0.2ml PCR tubes to compare the performance of ﬂuidic
versus in vitro synthesis. Additionally, negative controls
were conducted where construction oligos for synthesis
reactions were omitted from the mixes. These ‘primers-
only’ negative controls were run side-by-side in the
microﬂuidic device with synthesis mixtures containing
construction oligos. In vitro positive control experiments
were conducted in an MWG Primus 2500 thermocycler
utilizing the same thermocycle programs described above.
All ‘in ﬂuidic’ control experiments were similarly con-
ducted with the 100-thermocycle microchannel treatment,
discussed previously.
Polyacrylamide gel electrophoresis
Reaction mixtures collected from the four 500nl reactors
for all ‘in ﬂuidic’ syntheses and negative control experi-
ments along with 0.5ml of each positive in vitro control
were analyzed by PAGE (4–12% gradient TBE gel,
Invitrogen) and visualized by SYBR Gold staining
(Molecular Probes). Band intensities for synthesized
genes and gene segments were approximated utilizing
AlphaEaseFC software from Alpha Innotech
Corporation.
DNA sequencing
Gene synthesis products were sequenced to conﬁrm the
identities of the six target genes. Upon completion of
microﬂuidic gene synthesis and visualization by PAGE,
reaction mixtures that demonstrated successful synthesis
along with successful ‘in ﬂuidic’ negative controls were
further PCR ampliﬁed for 25 or 30 cycles to produce
larger quantities of DNA for sequencing. ‘Primers-only’
negative controls were again conducted alongside this
ampliﬁcation step to verify that only gene products from
the original microﬂuidic synthesis reaction and not a
contaminant species were ampliﬁed. Upon completion of
PCR, the resultant reaction mixtures were visualized by
PAGE to verify successful ampliﬁcation and the absence
e61 Nucleic Acids Research, 2007, Vol. 35, No. 8 PAGE 4 OF9of product in the negative controls. PCR products
were puriﬁed using QIAquick PCR Puriﬁcation Kits
(QIAGEN) prior to sequencing. It was subsequently
demonstrated (with the alba and DsRed genes) that gene
assembly products taken directly from the microﬂuidic
devices provided suﬃcient material for DNA sequencing,
after ﬁrst using ethanol precipitation to remove salts and
enzymes.
The GFP gene product was sequenced using internal
sequencing primers as in Carr et al. (14). All other gene
products were sequenced (top and bottom strands) using
the amplifying primers as sequencing primers, by the MIT
Biopolymers Laboratory.
To quantify the errors present in these synthetic genes,
one gene was chosen for further analysis. DsRed gene
synthesis products were cloned (without puriﬁcation or
secondary ampliﬁcation) into vector pCR4Blunt-TOPO
(Invitrogen) and transformed into chemically competent
DH5a cells. Individual colonies were picked and grown
in Luria-Bertani broth. Glycerol stocks of these cultures
were sent to Cogenics for plasmid extraction and
sequencing. One 96-well plate of samples was sequenced
(48 from cloned microﬂuidic-synthesized DsRed genes,
48 from the positive control synthesis reactions
performed in standard 0.2-ml PCR tubes). All sequence
reads were analyzed using the sequence-alignment
tool ClustalX, and each error was veriﬁed by direct
visual conﬁrmation of electropherograms using Chromas
(Technelysium).
RESULTS
Parallel gene syntheses were successfully conducted in a
PDMS-based microﬂuidic device, as visualized in the gel
shown in Figure 3 and ultimately veriﬁed by DNA
sequencing. Here, parallel synthesis of four gene and
gene segments, namely GFP segment 1 (531bp), GFP
segment 2 (529bp), the hjc gene from bacteriophage
SIRV-1 (390bp) and the randomized alba gene from S.
solfataricus (327bp), is demonstrated. Successful assembly
was also achieved for the four positive in vitro controls,
while successful ‘primers-only’ negative controls were
conducted both ‘in ﬂuidic’ and in vitro to conﬁrm that
the presence of desired-length product was not a
consequence of ampliﬁcation of contaminant species
(not shown). Strong, dominant bands are evident for the
desired products of all four ﬂuidic syntheses, with product
yields greater than 50% relative to the positive in vitro
controls (i.e. in PCR tubes). The lower molecular weight
species below the product bands indicate normal levels of
assembly intermediates for a single reaction PCA.
Additionally, the synthesis of four additional con-
structs, the full-length GFP construct (993bp), OR128-1
(942bp), DsRed (733bp), and ble (461bp) was also
accomplished, thus demonstrating the generality and
robustness of microﬂuidic gene synthesis. Lower oligonu-
cleotide concentrations (10nM) were required for the longer
genes (GFP, OR128-1 and DsRed), as it is hypothesized
that, at higher construction oligo concentrations, all
dNTPs are consumed generating intermediate products.
The results of the parallel syntheses of these four genes
along with their respective negative controls are shown in
Figure 4. Again, strong, dominant product bands are
observed for all four assemblies, while the negative controls
exhibit no discernable product bands. To obtain successful
negative controls as shown in Figure 4, signiﬁcant care must
be taken to eliminate all contamination, as the presence of
even minute quantities of template molecules can lead to
undesired ampliﬁcation—and thus erroneous results—in
both PCA and PCR. These negative controls have yet to fail
when appropriate care is taken to avoid contamination
(fresh reagents and thorough cleanliness of all lab surfaces
and equipment—pipettors and tips, PCR tubes, ﬂuidic
tubing, etc.).
In all cases, direct sequencing of microﬂuidic gene
synthesis products unambiguously conﬁrmed the identity
of each target gene. However, such sequencing does not
eﬀectively report on the rate of error in the product
material, as errors in individual molecules are eﬀectively
averaged out in the ensemble of products. Thus, one gene
product (DsRed, 733bp) was cloned, and the resultant
clones sequenced to quantify error rates. For DsRed
sequencing, puriﬁcation (by length or secondary ampliﬁ-
cation) was deliberately omitted to prevent the addition or
masking of errors in such processing. For the same reason,
clones were not screened prior to sequencing other than
blue/white screening to conﬁrm successful insertion into
the cloning vector. Thus, gene synthesis products (which
include the desired full-length species along with other
incomplete, intermediary products, as seen in Figure 4)
were cloned directly from the microﬂuidic device or PCR
tube upon veriﬁcation of synthesis by PAGE. The results
of this sequencing are shown in Table 1. Forty eight clones
for both ‘in ﬂuidic’ and in vitro DsRed synthesis yielded
Figure 3. Polyacrylamide gel electrophoresis (PAGE) showing success-
ful parallel synthesis of four gene and gene segments: GFP segment 1
(531bp), GFP segment 2 (529bp), the hjc gene from SIRV-1 (390bp),
and a variant alba gene from S. solfataricus (327bp). Positive in vitro
controls are shown side-by-side. Molecular weight markers are shown
(M) with 250, 500, and 750bp positions indicated.
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tively. A total of 29 and 30 errors were identiﬁed for the ‘in
ﬂuidic’ and in vitro DsRed syntheses, thus generating error
rates, per base, of 0.0018 and 0.0022, respectively, with an
overall per-base error rate for all sequence reads of 0.0020.
These values correspond well with the 0.0018 per-base
error rates for the unpuriﬁed synthesis products reported
by Carr et al. (14) and Hoover et al. (21), along with the
0.0027 per-base error rate reported by Kodumal et al. (13)
Given the 0.0018 per-base error rate for ‘in ﬂuidic
synthesis’, as calculated in Carr et al. (14), 9 DsRed
clones are required for sequencing to have a high
probability (95%) of at least one that is error-free.
Ultimately, 12.5% of full-length clones were error-free,
in agreement with theoretical expectations. For detailed
tabulation of sequencing results, see Supplementary
Table III.
DISCUSSION
Currently, the cost and time required to generate long,
high-ﬁdelity DNA molecules prevents such synthesis
technology from being an extensively utilized resource.
For example, at current oligo costs of approximately
110
1 dollars per base, applications such as the de novo
synthesis of bacterial genomes 10
6bp in size become
prohibitively costly, requiring on the order of USD100000
in oligos alone. Similarly, the ability to generate sets of
hundreds or thousands of single genes is restricted. The
costs of expensive reagents such as polymerase and
oligonucleotides can be signiﬁcantly reduced by utilizing
microﬂuidic technology to minimize reaction volumes to a
fraction of a microliter as compared to tens of microliters
required in conventional syntheses.
Further reductions in oligonucleotide costs by several
orders of magnitude can be achieved by utilizing the oligos
synthesized from DNA microarrays (11,18–19). In such
arrays, large numbers of distinct oligos are synthesized
massively in parallel [10
4–10
5 or more for a single high-
density array (25–26)] but in minute quantities (femto-
moles or less). Thus, each oligo in a microarray can cost as
little as 110
5 to 110
3 dollars per base, depending
on the array, which typically cost between a few hundred
to a few thousand dollars (e.g. USD489 for a 244000
spot Agilent microarray). These costs per base are orders
of magnitude less than for conventional oligo synthesis.
Thus, the current signiﬁcant contribution of oligo costs to
the overall price of gene synthesis could be reduced to an
almost trivial amount if the wealth of raw building
material provided by microarrays could be successfully
utilized. If maximally employed, oligo costs for building
a1 0
6bp genome could potentially be reduced to tens of
dollars. To achieve this goal, two diﬃculties must be
addressed: (1) conducting synthesis from the low yields of
each oligo in a microarray; and (2) problems that arise
from manipulating highly complex pools of oligonucleo-
tides (410
4 distinct sequences). In this work, successful
gene synthesis from minute oligo quantities (femtomoles)
utilizing a microﬂuidic device architecture has been
demonstrated, while such an architecture employed in
conjunction with a microarray has the potential to
overcome the limitations associated with complex pool
manipulation.
A
B
Figure 4. Polyacrylamide gel electrophoresis (PAGE) showing success-
ful parallel synthesis of genes along with negative controls. In the
presence of construction oligos, DNA constructs GFP and dsRed (993
and 733bp, respectively; Figure 4A) and OR128-1 and ble (942 and
461bp, respectively; Figure 4B) are synthesized and ampliﬁed. Without
construction oligos, no product bands are generated. Molecular weight
markers are shown (M) with 500, 750 and 1000bp positions indicated.
Table 1. Summary of errors for synthesis of DsRed in the microﬂuidic
device as compared to in a standard PCR tube
Error type Microﬂuidic device PCR tube
Deletion Single-base 19 16
Deletion Multiple-base 5 5
Transition G/C to A/T 3 6
Transition A/T to G/C 0 2
Transversion G/C to C/G 0 0
Transversion G/C to T/A 1 1
Transversion A/T to C/G 1 0
Transversion A/T to T/A 0 0
Total errors: 29 30
Bases sequenced: 16250 13389
Error rate (per base): 0.0018 0.0022
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format have been cleaved from the arrays and collected in
‘large’ volumes (e.g. 5ml or more) (11,18–19). The
resulting low concentrations of oligo have been below
the minimum needed to perform gene synthesis. Thus,
additional process steps such as DNA concentration
and/or ampliﬁcation by PCR were required in order to
assemble genes from this raw material. Direct gene
synthesis of microarray oligos in microﬂuidic reactors
such as the ones presented here can circumvent these
requirements by conﬁning synthesis reactions to indivi-
dual chambers, thus maintaining oligo concentrations at
levels suﬃcient for synthesis. Table 2 indicates the
concentrations of construction oligos expected for two
diﬀerent microarrays (25,26) (Agilent, Nimblegen) for a
reactor enclosing 16 oligo spots, suﬃcient to build a
400bp gene. Using a reasonable estimate for oligo yields
as function of spot area [0.1pmol/mm
2, as in Richmond
et al. (18); as much as 4pmol/mm
2 have been estimated
(27). See also Pirrung (28) for further discussion of oligo
density], the spot size and spacing for the two microarrays,
and assuming a chamber with the same height as the
reactors used in this work (10mm), we estimate that
construction oligos can be conﬁned to yield concentra-
tions in excess of 200nM each. This is substantially larger
than the 10–25nM per oligo utilized for microﬂuidic
synthesis reported here. Thus, ample room for error is
provided to account for low oligo synthesis and/or
cleavage yields, as well as chambers enclosing more oligo
spots to synthesize larger genes. Employing such direct
synthesis without concentration or an initial ampliﬁcation
step not only reduces the time and cost of the overall
synthesis protocol, but also eliminates the possibility that
additional errors will be generated during the ampliﬁca-
tion procedure. The oligonucleotide building blocks
themselves are currently the greatest source of error in
synthesized products; therefore, reducing the likelihood of
further inaccuracies is crucial for obtaining high-quality
synthetic DNA.
Resolving hundreds of thousands of oligos into reac-
tions generating thousands of genes is a non-trivial
challenge. For example, while multiplex gene synthesis
utilizing bulk sample handling has been impressively
demonstrated from an oligo pool containing 600 distinct
oligonucleotides (11), we expect such ampliﬁcations to
become unfeasible for pools of higher complexity. Just as
multiplex PCR suﬀers from inconsistencies such that each
template may not be equally ampliﬁed (29), similarly the
simultaneous ampliﬁcation and subsequent assembly of
10
5 or more sequences is unlikely to proceed evenly. For
gene synthesis, this is expected to be limiting; if the pool
becomes dominated by a few DNA species, the required
pool diversity would be lost, rendering assembly impos-
sible. The absence of a single oligo prevents the assembly
of its corresponding gene, so that losses even as low as
0.1% could interfere with the production of dozens or
hundreds of genes. Correspondingly, other reagent con-
centrations become impacted by the complexity of oligo
pools. For example, if only 1 nM of each construction
oligo were required for synthesis (a low estimate), for a
pool of 10
5 oligos the starting material would be 0.1mM,
meaning that virtually all the required deoxynucleotide
(dNTP) precursors used by DNA polymerase would be
consumed in the ﬁrst cycle of a PCA reaction, terminating
the reaction before generating the desired product. Use
of a microﬂuidic device architecture such as the one
presented in this work to enclose sets of oligo spots for
gene synthesis would maintain reagent concentrations at
desired levels while eliminating unwanted interference
between sets of oligonucleotides in a complex pool. In the
case of parallel synthesis of genes with related sequences
(e.g. many variants of the same gene), avoiding undesired
oligo annealing events during assembly will be crucial.
In this work we report, to our knowledge, the ﬁrst gene
synthesis in a microﬂuidic environment. Genes and gene
segments with sizes as large as a kilobase were assembled
in four parallel reactors in a single device. Reactions were
conducted in 500nl chambers, which are reaction volumes
one to two orders of magnitude smaller than those used in
conventional gene synthesis, thus achieving substantial
reductions in reagent costs. This work also demonstrates
the feasibility of utilizing such device architecture in
conjunction with high-density oligonucleotide microarrays
to potentially further reduce costs by several orders of
magnitude. Microﬂuidic syntheses were successfully con-
ducted at low construction oligonucleotide concentrations
of 10–25nM, values substantially lower than the antici-
pated concentration attainable from microarrays. By
enclosing microarray oligos in microﬂuidic chambers,
the currently required complex pool handling would be
eliminated while enabling researchers, in principle, to
maximally harness the high density of oligonucleotides
present on a microarray. The eﬀective use of such
architecture in combination with high-density oligo
microarrays would constitute a major step toward
realizing the goal of low cost de novo gene synthesis.
While this work utilized four parallel 500nl chambers
to facilitate analysis of reaction products via PAGE, both
the number and volume of reactors can be scaled
substantially. Previous work has demonstrated PCR in
volumes as small as 86pl (30), and a 100pl chamber with
dimensions of 100mm100mm10mm capable of enclos-
ing groups of 16 oligonucleotides (described in the
calculations in Table 1) can be fabricated with ease
Table 2. Calculations for expected oligonucleotide yields from a typical
DNA microarray for 16 oligonucleotides, suﬃcient to build a 400bp
gene. Values for spot area and spot spacing are for commercially
available Agilent and Nimblegen DNA microarrays
Agilent Nimblegen
Area of spot 1.410
4mm
2 2.5610
2mm
2
Oligo density 0.1pmol/mm
2 0.1pmol/mm
2
Maximum expected
yield per spot
1.4fmol 0.0256fmol
Dimensions of spot spacing 212mm by 188mm2 5 mmb y2 5 mm
Minimal footprint of
16 oligo spots
6.410
5mm
2 110
4mm
2
Minimal chamber volume
(10mm height)
6.4nl 100pl
Estimated concentration
of each oligo
220nM 256nM
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microﬂuidic devices containing a high density of reactors
for massively parallel gene synthesis is being currently
investigated.
While fusion of microﬂuidic handling with oligo
microarrays will provide the ﬁrst step in making gene
synthesis more available to researchers, integration with
further microﬂuidic functions will allow this technology to
mature. These advances will include:
(1) Incorporation of existing DNA error correction
techniques (11,14–16) on-chip to improve the quality
of the synthesis products. This will help minimize the
need for another substantial contribution to the cost
and time of gene synthesis: quality control (i.e.
typically cloning and sequencing). While the device
described in this work does not integrate on-chip
error correction, it can be used readily with existing
DNA error correction techniques both before and
after synthesis. For example, construction oligos can
ﬁrst be gel-puriﬁed, as demonstrated by Hutchinson
et al. (6), prior to conducting gene synthesis in the
microﬂuidic device, or alternatively the MutS error-
ﬁlter described by Carr et al. (14) could be performed
on reaction mixtures collected from the device upon
completion of synthesis. Thus, the microﬂuidic device
can complement these bench-top error correction
methods while providing the associated beneﬁts of
reduced reagent costs during synthesis. For certain
in vitro applications, cloning will not necessarily be
required.
(2) A second application will be the integration of
in vitro protein expression using high quality
synthetic DNA as a template.
(3) Finally, assembly of constructs larger than single
genes can be achieved with microﬂuidic devices,
employing the same types of hierarchical in vitro
assembly reactions used to create 12kb and larger
segments (11–12).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
The authors would like to gratefully acknowledge Brian
Chow, Johnson Hou, Mayank Kumar and J.P. Urbanski
for helpful discussion, Byron Hsu for assistance with Lab
VIEW, and Scott Manalis for the generous use of various
fabrication equipment. This work has been supported by
NSF/CBA grant CCR-0122419. Funding to pay the Open
Access publication charges for this article was provided by
the Center for Bits and Atoms.
Conﬂict of interest statement. None declared.
REFERENCES
1. Khorana,H.G. (1968) Nucleic acid synthesis in the study of
the genetic code, in Nobel Lectures: Physiology or Medicine
(1963–1970), Elsevier Science Ltd, Amsterdam, 341–369.
2. The MGC Project Team (2004) The status, quality, and expansion
of the NIH full-length cDNA project: the mammalian gene
collection (MGC). Genome Res., 14, 2121–2127.
3. Elowitz,M.B. and Leibler,S. (2000) A synthetic oscillatory network
of transcriptional regulators. Nature, 403, 335–338.
4. Martin,V.J., Pietera,D.J., Withers,S.T., Newman,J.D. and
Keasling,J.D. (2003) Engineering a mevalonate pathway in
Escherichia coli for production of terpenoids. Nat. Biotechnol., 21,
796–802.
5. Cello,J., Paul,A.V. and Wimmer,E. (2002) Chemical synthesis of
poliovirus cDNA: generation of infectious virus in the absence of
natural template. Science, 297, 1016–1018.
6. Smith,H.O., Hutchison,C.A., III, Pfannkoch,C. and Venter,J.C.
(2003) Generating a synthetic genome by whole genome assembly:
phiX174 bacteriophage from synthetic oligonucleotides.
Proc. Natl. Acad. Sci. USA, 100, 15440–15445.
7. Hutchison,C.A., III, Peterson,S.N., Gill,S.R., Cline,R.T., White,O.,
Fraser,C.M., Smith,H.O. and Venter,J.C. (1999) Global transposon
mutagenesis and a minimal mycoplasma genome. Science, 286,
2165–2169.
8. Caruthers,M.H. (1985) Gene synthesis machines: DNA chemistry
and its uses. Science, 230, 281–285.
9. Mullis,K., Faloona,F., Scharf,S., Saiki,R., Horn,G. and Erlich,H.
(1986) Speciﬁc enzymatic ampliﬁcation of DNA in vitro: the
polymerase chain reaction. Cold Spring Harb. Symp. Quant. Biol.,
51, 263–273.
10. Stemmer,W.P., Crameri,A., Ha,K.D., Brennan,T.M. and
Heyneker,H.L. (1995) Single-step assembly of a gene and entire
plasmid from large numbers of oligonucleotides. Gene, 164, 49–53.
11. Tian,J., Gong,H., Sheng,N., Zhou,X., Gulari,E., Gao,X. and
Church,G. (2004) Accurate multiplex gene synthesis from pro-
grammable DNA microchips. Nature, 432, 1050–1054.
12. Xiong,A.S., Yao,Q.H., Peng,R.H., Duan,H., Li,X., Fan,H.Q.,
Cheng,Z.M. and Li,Y. (2006) PCR-based accurate synthesis of long
DNA sequences. Nature Protocols, 1, 791–797.
13. Kodumal,S.J., Patel,K.G., Reid,R., Menzella,H.G., Welch,M. and
Santi,D.V. (2004) Total synthesis of long DNA sequences: synthesis
of a contiguous 32-kb polyketide synthase gene cluster.
Proc. Natl. Acad. Sci. USA, 101, 15573–15578.
14. Carr,P.A., Park,J.S., Lee,Y.J., Yu,T., Zhang,S. and Jacobson,J.M.
(2004) Protein-mediated error correction for de novo DNA
synthesis. Nucleic Acids Res., 32, e162.
15. Binkowski,B.F., Richmond,K.E., Kaysen,J., Sussman,M.R. and
Belshaw,P.J. (2005) Correcting errors in synthetic DNA through
consensus shuﬄing. Nucleic Acids Res., 33, e55.
16. Fuhrmann,M., Oertel,W., Berthold,P. and Hegemann,P. (2005)
Removal of mismatched bases from synthetic genes by enzymatic
mismatch cleavage. Nucleic Acids Res., 33, e58.
17. Liu,J., Hansen,C. and Quake,S.R. (2003) Solving the ‘world-to-
chip’ interface problem with a microﬂuidic matrix. Anal. Chem., 75,
4718–4723.
18. Richmond,K.E., Li,M.H., Rodesch,M.J., Patel,M., Lowe,A.M.,
Kim,C., Chu,L.L., Venkataramaian,N., Flickinger,S.F. et al. (2004)
Ampliﬁcation and assembly of chip-eluted DNA (AACED): a
method for high-throughput gene synthesis. Nucleic Acids Res., 32,
5011–5018.
19. Zhou,X., Cai,S., Hong,A., You,Q., Yu,P., Sheng,N.,
Srivannavit,O., Muranjan,S., Rouillard,J.M. et al. (2004)
Microﬂuidic PicoArray synthesis of oligodeoxynucleotides and
simultaneous assembling of multiple DNA sequences.
Nucleic Acids Res., 32, 5409–5417.
20. Unger,M.A., Chou,H.P., Thorsen,T., Scherer,A. and Quake,S.R.
(2000) Monolithic microfabricated valves and pumps by multilayer
soft lithography. Science, 288, 113–6.
21. Hoover,D.M. and Lubkowski,J. (2002) DNAWorks: an
automated method for designing oligonucleotides for PCR-based
gene synthesis. Nucleic Acids Res., 30, e43.
22. Shoﬀner,M.A., Cheng,J., Hvichia,G.E., Kricka,L.J. and Wilding,P.
(1996) Chip PCR. I. Surface passivation of microfabricated silicon-
glass chips for PCR. Nucleic Acids Res., 24, 375–379.
23. Huang,B., Wu,H., Kim,S. and Zare,R.N. (2005) Coating of
poly(dimethylsiloxane) with n-dodecyl-beta-D-maltoside to mini-
mize nonspeciﬁc protein adsorption. Lab. Chip, 5, 1005–1007.
e61 Nucleic Acids Research, 2007, Vol. 35, No. 8 PAGE 8 OF924. Panaro,N.J., Lou,X.J., Fortina,P., Kricka,L.J. and Wilding,P.
(2004) Surface eﬀects on PCR reactions in multichip microﬂuidic
platforms. Biomedical Microdevices, 6, 75–80.
25. Cleary,M.A., Kilian,K., Wang,Y., Bradshaw,J., Cavet,G., Ge,W.,
Kulkarni,A., Paddison,P.J., Chang,K. et al. (2004) Production of
complex nucleic acid libraries using highly parallel in situ
oligonucleotide synthesis. Nature Methods, 1, 241–248.
26. Nuwaysir,E.F., Huang,W., Albert,T.J., Singh,J., Nuwaysir,K.,
Pitas,A., Richmond,T., Gorski,T., Berg,J.P. et al. (2002) Gene
expression analysis using oligonucleotide arrays produced by
maskless photolithography. Genome. Res., 12, 1749–1755.
27. Elder,J.K., Johnson,M., Milner,N., Mir,K.U., Sohail,M. and
Southern,E.M. (1999) DNA Microarrays. In Schena,M. (ed),
A Practical Approach. Oxford Press, New York, 77–99.
28. Pirrung,M.C. (2002) How to make a DNA chip. Angew. Chem. Int.
Ed., 41, 1276–1289.
29. Edwards,M.C. and Gibbs,R.A. (1994) Multiplex PCR:
advantages, development, and applicationsz. PCR Methods Appl., 3,
S65–S75.
30. Nagai,H., Murakami,Y., Morita,Y., Yokoyama,K. and Tamiya,E.
(2001) Development of a microchamber array for picoliter PCR.
Anal. Chem., 73, 1043–1047.
PAGE 9 OF 9 Nucleic Acids Research, 2007, Vol. 35, No. 8 e61